Achilles Therapeutics (ACHL)

ACHL was delisted on the 20th of March, 2025.

• Market cap: $60.8M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Employees: 215